Zhanfang Kang

554 total citations
23 papers, 434 citations indexed

About

Zhanfang Kang is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Zhanfang Kang has authored 23 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Zhanfang Kang's work include Metabolism, Diabetes, and Cancer (7 papers), Pancreatic function and diabetes (6 papers) and Diabetes Treatment and Management (5 papers). Zhanfang Kang is often cited by papers focused on Metabolism, Diabetes, and Cancer (7 papers), Pancreatic function and diabetes (6 papers) and Diabetes Treatment and Management (5 papers). Zhanfang Kang collaborates with scholars based in China, Sweden and Taiwan. Zhanfang Kang's co-authors include Chi‐Wai Wong, Fang Fang, Rongrong Fan, Dazhong Yin, Juliana C.N. Chan, Gang Xu, Jun Gao, Fengjuan Li, Wenjuan Tan and Xiao‐Jing Zhang and has published in prestigious journals such as PLoS ONE, Oncogene and The FASEB Journal.

In The Last Decade

Zhanfang Kang

22 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhanfang Kang China 11 164 110 88 84 71 23 434
Eugenia Belcastro France 12 186 1.1× 167 1.5× 94 1.1× 81 1.0× 33 0.5× 30 600
Tinoy Kizhakekuttu United States 7 219 1.3× 82 0.7× 53 0.6× 171 2.0× 53 0.7× 12 586
Annamaria Tavernese Italy 14 174 1.1× 50 0.5× 64 0.7× 71 0.8× 45 0.6× 40 509
Lorena Bellod Spain 12 168 1.0× 97 0.9× 96 1.1× 75 0.9× 34 0.5× 13 402
Luxiao Li China 9 296 1.8× 60 0.5× 93 1.1× 57 0.7× 44 0.6× 10 681
Kwazi Gabuza South Africa 13 159 1.0× 91 0.8× 35 0.4× 69 0.8× 32 0.5× 22 468
M. J. Lee South Korea 6 82 0.5× 121 1.1× 61 0.7× 95 1.1× 60 0.8× 6 481
Emma Waddington Australia 8 139 0.8× 38 0.3× 73 0.8× 50 0.6× 62 0.9× 9 360
Atef N. Hanna United States 14 221 1.3× 121 1.1× 52 0.6× 57 0.7× 40 0.6× 24 566
Derek Y.C. Yuen Australia 7 163 1.0× 54 0.5× 64 0.7× 87 1.0× 52 0.7× 7 413

Countries citing papers authored by Zhanfang Kang

Since Specialization
Citations

This map shows the geographic impact of Zhanfang Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanfang Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanfang Kang more than expected).

Fields of papers citing papers by Zhanfang Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanfang Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanfang Kang. The network helps show where Zhanfang Kang may publish in the future.

Co-authorship network of co-authors of Zhanfang Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanfang Kang. A scholar is included among the top collaborators of Zhanfang Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanfang Kang. Zhanfang Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaojing, Xianying Zhang, Ling Lai, et al.. (2025). The miR-941/FOXN4/TGF-β feedback loop induces N2 polarization of neutrophils and enhances tumor progression of lung adenocarcinoma. Frontiers in Immunology. 16. 1561081–1561081. 2 indexed citations
2.
Liu, Zhi‐Jie, Baojian Guo, Qingbin Cui, et al.. (2024). Pharmacological Mechanisms of Periplocae Cortex Against Congestive Heart Failure Based on Network Pharmacology and Experimental Evaluation. Natural Product Communications. 19(3).
3.
Kang, Zhanfang, et al.. (2024). DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer. Oncogene. 43(19). 1399–1410. 6 indexed citations
4.
Li, Jingxuan, Xun Yuan, Yilang Li, et al.. (2024). BRG1 Deficiency Promotes Cardiomyocyte Inflammation and Apoptosis by Activating the cGAS-STING Signaling in Diabetic Cardiomyopathy. Inflammation. 48(1). 299–315. 6 indexed citations
5.
Zhang, Xueji, Baoyi Zhu, Jun Gao, et al.. (2023). Naringenin protects pancreatic β cells in diabetic rat through activation of estrogen receptor β. European Journal of Pharmacology. 960. 176115–176115. 9 indexed citations
6.
Zhang, Xiao‐Jing, Zhanfang Kang, Dazhong Yin, & Jun Gao. (2023). Role of neutrophils in different stages of atherosclerosis. Innate Immunity. 29(6). 97–109. 27 indexed citations
7.
Liu, Xiaoping, et al.. (2023). DT-010 Exerts Cardioprotective Effects by Regulating the Crosstalk between the AMPK/PGC-1α Pathway and ERp57. Cardiovascular Therapeutics. 2023. 1–11. 3 indexed citations
8.
Zhang, Xiaojing, Baoyi Zhu, Xiaoping Liu, et al.. (2022). Niacin exacerbates β cell lipotoxicity in diet-induced obesity mice through upregulation of GPR109A and PPARγ2: Inhibition by incretin drugs. Frontiers in Endocrinology. 13. 1057905–1057905. 5 indexed citations
9.
10.
Zhu, Baoyi, Zhanfang Kang, Yuying Zhang, et al.. (2022). Multi-Omics Characterization of Circular RNA-Encoded Novel Proteins Associated With Bladder Outlet Obstruction. Frontiers in Cell and Developmental Biology. 9. 772534–772534. 3 indexed citations
11.
Zhang, Bin, et al.. (2021). Erk phosphorylation reduces the thymoquinone toxicity in human hepatocarcinoma. Environmental Toxicology. 36(10). 1990–1998. 8 indexed citations
12.
Gao, Jun, et al.. (2020). Metformin scavenges formaldehyde and attenuates formaldehyde‐induced bovine serum albumin crosslinking and cellular DNA damage. Environmental Toxicology. 35(11). 1170–1178. 10 indexed citations
13.
14.
Yang, Xiaowei, Yi Sui, Fangfang Liu, et al.. (2020). Clinical Characteristics and Convalescent Plasma Therapy in Severe and Critically Ill COVID-19 Patients. SSRN Electronic Journal. 7 indexed citations
15.
Gao, Jun, et al.. (2017). The F0F1 ATP synthase regulates human neutrophil migration through cytoplasmic proton extrusion coupled with ATP generation. Molecular Immunology. 90. 219–226. 10 indexed citations
16.
Kang, Zhanfang, Yi Deng, Yinggang Zhou, et al.. (2012). Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes. Diabetologia. 56(2). 423–433. 51 indexed citations
17.
Fan, Rongrong, Zhanfang Kang, Lan He, Juliana C.N. Chan, & Gang Xu. (2011). Exendin-4 Improves Blood Glucose Control in Both Young and Aging Normal Non-Diabetic Mice, Possible Contribution of Beta Cell Independent Effects. PLoS ONE. 6(5). e20443–e20443. 29 indexed citations
18.
Li, Fengjuan, Wenjuan Tan, Zhanfang Kang, & Chi‐Wai Wong. (2010). Tocotrienol enriched palm oil prevents atherosclerosis through modulating the activities of peroxisome proliferators-activated receptors. Atherosclerosis. 211(1). 278–282. 32 indexed citations
19.
Fang, Fang, Zhanfang Kang, & Chi‐Wai Wong. (2009). Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator‐activated receptors. Molecular Nutrition & Food Research. 54(3). 345–352. 103 indexed citations
20.
Kang, Zhanfang, et al.. (2005). Reaction of pyridoxamine with malondialdehyde: Mechanism of inhibition of formation of advanced lipoxidation end-products. Amino Acids. 30(1). 55–61. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugenia Belcastro Breakdown of academic impact, for papers by Tinoy Kizhakekuttu Breakdown of academic impact, for papers by Annamaria Tavernese Breakdown of academic impact, for papers by Lorena Bellod Breakdown of academic impact, for papers by Luxiao Li Breakdown of academic impact, for papers by Kwazi Gabuza Breakdown of academic impact, for papers by M. J. Lee Breakdown of academic impact, for papers by Emma Waddington Breakdown of academic impact, for papers by Atef N. Hanna Breakdown of academic impact, for papers by Derek Y.C. Yuen
Rankless by CCL
2026